Stay updated on PD-1 Inhibition in Advanced MPNs Clinical Trial
Sign up to get notified when there's something new on the PD-1 Inhibition in Advanced MPNs Clinical Trial page.

Latest updates to the PD-1 Inhibition in Advanced MPNs Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedMajor update: new operating-status notice and version revision to v3.2.0; removal of an old topic (Acquired polycythemia vera) is less impactful.SummaryDifference3%
- Check21 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%
- Check28 days agoChange DetectedNo changes detected. The page content appears unchanged.SummaryDifference0.4%
- Check35 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; a minor UI element ('Back to Top') was removed. No changes to pricing, stock, times, or names.SummaryDifference0.4%
- Check42 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.6%
- Check49 days agoChange DetectedThe web page has added specific details about a facility and its location, including the Bronx, New York, and information related to acquired polycythemia vera and pembrolizumab, while removing several related medical topics and terms.SummaryDifference5%
Stay in the know with updates to PD-1 Inhibition in Advanced MPNs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 Inhibition in Advanced MPNs Clinical Trial page.